vs
Esperion Therapeutics, Inc.（ESPR）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Purple Innovation, Inc.的1.2倍（$168.4M vs $140.7M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 9.1%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 8.3%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
ESPR vs PRPL — 直观对比
营收规模更大
ESPR
是对方的1.2倍
$140.7M
营收增速更快
ESPR
高出134.6%
9.1%
两年增速更快
ESPR
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $140.7M |
| 净利润 | — | $-3.2M |
| 毛利率 | — | 41.9% |
| 营业利润率 | 50.6% | -1.6% |
| 净利率 | — | -2.3% |
| 营收同比 | 143.7% | 9.1% |
| 净利润同比 | — | 62.1% |
| 每股收益（稀释后） | $0.32 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPRPL
| Q4 25 | $168.4M | $140.7M | ||
| Q3 25 | $87.3M | $118.8M | ||
| Q2 25 | $82.4M | $105.1M | ||
| Q1 25 | $65.0M | $104.2M | ||
| Q4 24 | $69.1M | $129.0M | ||
| Q3 24 | $51.6M | $118.6M | ||
| Q2 24 | $73.8M | $120.3M | ||
| Q1 24 | $137.7M | $120.0M |
净利润ESPRPRPL
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-31.3M | $-11.7M | ||
| Q2 25 | $-12.7M | $-17.3M | ||
| Q1 25 | $-40.5M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $-29.5M | $-39.2M | ||
| Q2 24 | $-61.9M | $27.0K | ||
| Q1 24 | $61.0M | $-50.2M |
毛利率ESPRPRPL
| Q4 25 | — | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | — | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 34.8% |
营业利润率ESPRPRPL
| Q4 25 | 50.6% | -1.6% | ||
| Q3 25 | -11.4% | -10.2% | ||
| Q2 25 | 8.6% | -13.5% | ||
| Q1 25 | -34.0% | -13.9% | ||
| Q4 24 | -6.4% | -6.0% | ||
| Q3 24 | -31.0% | -39.5% | ||
| Q2 24 | 3.5% | -12.1% | ||
| Q1 24 | 52.5% | -19.3% |
净利率ESPRPRPL
| Q4 25 | — | -2.3% | ||
| Q3 25 | -35.9% | -9.9% | ||
| Q2 25 | -15.4% | -16.5% | ||
| Q1 25 | -62.2% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | -57.2% | -33.1% | ||
| Q2 24 | -83.9% | 0.0% | ||
| Q1 24 | 44.3% | -41.8% |
每股收益（稀释后）ESPRPRPL
| Q4 25 | $0.32 | $0.03 | ||
| Q3 25 | $-0.16 | $0.11 | ||
| Q2 25 | $-0.06 | $0.16 | ||
| Q1 25 | $-0.21 | $0.18 | ||
| Q4 24 | $-0.14 | $0.08 | ||
| Q3 24 | $-0.15 | $0.36 | ||
| Q2 24 | $-0.33 | $0.00 | ||
| Q1 24 | $0.34 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $24.3M |
| 总债务越低越好 | — | $126.7M |
| 股东权益账面价值 | $-302.0M | $-29.7M |
| 总资产 | $465.9M | $296.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRPRPL
| Q4 25 | $167.9M | $24.3M | ||
| Q3 25 | $92.4M | $32.4M | ||
| Q2 25 | $86.1M | $34.2M | ||
| Q1 25 | $114.6M | $21.6M | ||
| Q4 24 | $144.8M | $29.0M | ||
| Q3 24 | $144.7M | $23.4M | ||
| Q2 24 | $189.3M | $23.4M | ||
| Q1 24 | $226.6M | $34.5M |
总债务ESPRPRPL
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESPRPRPL
| Q4 25 | $-302.0M | $-29.7M | ||
| Q3 25 | $-451.4M | $-26.9M | ||
| Q2 25 | $-433.5M | $-15.6M | ||
| Q1 25 | $-426.2M | $1.3M | ||
| Q4 24 | $-388.7M | $20.2M | ||
| Q3 24 | $-370.2M | $28.0M | ||
| Q2 24 | $-344.2M | $66.4M | ||
| Q1 24 | $-294.3M | $65.5M |
总资产ESPRPRPL
| Q4 25 | $465.9M | $296.3M | ||
| Q3 25 | $364.0M | $302.1M | ||
| Q2 25 | $347.1M | $303.8M | ||
| Q1 25 | $324.0M | $293.8M | ||
| Q4 24 | $343.8M | $307.8M | ||
| Q3 24 | $314.1M | $309.3M | ||
| Q2 24 | $352.3M | $362.1M | ||
| Q1 24 | $373.1M | $382.1M |
负债/权益比ESPRPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.8M |
| 自由现金流率自由现金流/营收 | — | -5.5% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-41.9M |
8季度趋势，按日历期对齐
经营现金流ESPRPRPL
| Q4 25 | $45.2M | $-5.8M | ||
| Q3 25 | $-4.3M | $-968.0K | ||
| Q2 25 | $-31.4M | $-4.0M | ||
| Q1 25 | $-22.6M | $-23.1M | ||
| Q4 24 | $-35.0M | $6.8M | ||
| Q3 24 | $-35.3M | $1.1M | ||
| Q2 24 | $-7.2M | $-8.9M | ||
| Q1 24 | $53.8M | $-16.8M |
自由现金流ESPRPRPL
| Q4 25 | — | $-7.8M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-7.0M | ||
| Q1 25 | — | $-25.3M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | $-35.5M | $101.0K | ||
| Q2 24 | $-7.3M | $-11.0M | ||
| Q1 24 | $53.8M | $-19.9M |
自由现金流率ESPRPRPL
| Q4 25 | — | -5.5% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | — | -6.6% | ||
| Q1 25 | — | -24.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | -68.7% | 0.1% | ||
| Q2 24 | -9.9% | -9.2% | ||
| Q1 24 | 39.0% | -16.5% |
资本支出强度ESPRPRPL
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.1% | 1.7% | ||
| Q1 24 | 0.1% | 2.5% |
现金转化率ESPRPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
